Optimum Nutrition
1
/
of
2
Allmax Fadogia Agrestis 325mg, 120 Capsules
Allmax Fadogia Agrestis 325mg, 120 Capsules
No reviews
No reviews
Regular price
$14.99 USD
Regular price
$29.99 USD
Sale price
$14.99 USD
Shipping calculated at checkout.
Quantity
Couldn't load pickup availability
The full picture
Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →
32/100
Rejected
Six-dimension breakdown
Evidence
25
Formulation
45
Manufacturing
55
Safety
35
Transparency
55
Sustainability
50
Why this scored 32/100
Allmax Fadogia Agrestis at 325 mg per cap has the same fundamental problem as any Fadogia SKU: zero human RCTs, and the sole preclinical support (Yakubu 2005 in rats) documented dose-dependent testicular toxicity, kidney damage, and reduced sperm count. Allmax is a mid-tier bodybuilding-market brand with reasonable manufacturing but no ability to compensate for an ingredient that lacks a human evidence base and carries a rodent safety signal. Clean labeling (single ingredient, disclosed dose) is a modest positive. Autofailed under unverified_medical_claim. Would not be reconsidered above Rejected until published human safety and efficacy trials exist for Fadogia.
Last scored: Full rubric →
Evidence & sources
The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.
Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.
How to read the Evidence dimension
- 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
- 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
- 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
- 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
- 0–19: No credible evidence base or unverifiable claims.
FAQ data has not been generated for this product yet. See the site FAQ for general questions.
Customer reviews
Reviews on other platforms
The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.
All the data we have on this product
Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.
- VSF score
- 32 / 100
- Tier
- Rejected
- Category
- Supplements
- Subcategory
- mens health
- Last scored
- Third-party certifications
- None on record at time of scoring
- Vendor
- PoorBoySupplements.com
- Product type
- Testosterone Boosters
- Tags
- PoorBoySupplements.com, Shopify Collective
Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.
Share
